Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 9 von 569
World journal of gastroenterology : WJG, 2009-07, Vol.15 (28), p.3462-3471
2009

Details

Autor(en) / Beteiligte
Titel
Alcoholic liver disease and hepatitis C: A frequently underestimated combination
Ist Teil von
  • World journal of gastroenterology : WJG, 2009-07, Vol.15 (28), p.3462-3471
Ort / Verlag
United States: Department of Medicine and Center for Alcohol Research, Liver Disease and Nutrition, Salem Medical Center, University of Heidelberg, Zeppelinstraβe 11-33, 69121 Heidelberg, Germany
Erscheinungsjahr
2009
Link zum Volltext
Quelle
EZB Electronic Journals Library
Beschreibungen/Notizen
  • Alcoholic liver disease (ALD) and hepatitis C virus (HCV) infection represent, either alone or in combination, more than two thirds of all patients with liver disease in the Western world. This review discusses the epidemiology and combined impact of ALD and HCV on the progression of liver disease. ALD and HCV affect the progression of liver disease to liver cirrhosis and hepatocellular carcinoma (HCC) in a synergistic manner. Thus, the risk for HCC increases five times with a daily alcohol consumption of 80 g, in the presence of HCV it is increased 20-fold, and a combination of both risk factors leads to a more than 100-fold risk for HCC development. Alcohol consumption also decreases the response to interferon treatment which is probably due to a lack of compliance than a direct effect on HCV replication. Several molecu- lar mechanisms are discussed that could explain the synergistic interaction of alcohol and HCV on disease progression. They include modulation of the immune response and apoptosis, increased oxidative stress via induction of CYP2E1 and the hepatic accumulation of iron. Thus, both HCV and alcohol independently cause hepatic iron accumulation in 〉 50% of patients probably due to suppression of the liver-secreted systemic iron hormone hepcidin. A better understanding of hepcidin regulation could help in developing novel therapeutic approaches to treat the chronic disease in the future. For now, it can be generally concluded that HCV-infect- ed patients should abstain from alcohol and alcoholics should be encouraged to participate in detoxification programs.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX